Patent ID: 11921119
Assignee: MEMED DIAGNOSTICS LTD.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 0:
1. A method of determining a management course for a subject who has a diagnosis as having a severe coronaviral infection, comprising:
(a) measuring the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein level in a blood sample of the subject, wherein when the TRAIL level is above 145 pg/ml, the method further comprises:
(b) carrying out a management course selected from the group consisting of: (i) cessation of mechanical ventilation, (ii) cessation of invasive monitoring, (iii) cessation of last-resort drug administration, (iv) cessation of sedation, (v) transfer out of intensive care; and (vi) release from hospital.